LOS ANGELES, July 01, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB)—In recent days, Enochian BioSciences (the Company) has conducted a rigorous internal review of scientific data to give partners and ...
If convicted of the federal grand jury charges against them, Gumrukcu and Eratay face mandatory life in prison or the death penalty. Shares of the company’s stock plummeted 38.8% on the news. 3 Summer ...
It's not every day that a biotech's scientific co-founder is arrested on murder-for-hire charges. But the aftermath of that arrest is just what Enochian Biosciences' CEO faces now—and he's fighting ...
SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Enochian Biosciences Inc. (NASDAQ: ENOB) securities between January 17, 2018 and ...
LOS ANGELES, Oct. 18, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today ...
Enochian Biosciences is a pre-clinical stage biotech that purchased its HIV drug IP from Weird Science, LLC. ENOB's lead scientist and HIV IP inventor does not appear to have any biotech experience, ...
LOS ANGELES, May 25, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). The Board of Directors of Enochian BioSciences Inc. met today and expressed unanimous and strong affirmation of the current position of ...
SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Enochian Biosciences Inc. (NASDAQ: ENOB) securities between January 17, 2018 and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results